Handa Pharmaceuticals, Inc.

TPEX:6620 Stock Report

Market Cap: NT$8.2b

Handa Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 6620?
Owner TypeNumber of SharesOwnership Percentage
Institutions2,081,8161.47%
Individual Insiders5,403,8523.83%
Public Companies8,101,3495.74%
Private Companies42,188,81029.9%
General Public83,426,17359.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 17 shareholders own 40.92% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.5%
Liu Handa Holdings, LLC
27,562,000NT$1.6b0%no data
5.74%
Catalent, Inc.
8,101,349NT$468.3m0%no data
3.74%
Yuli Electric Co., Ltd.
5,283,051NT$305.4m0%no data
2.94%
Raypharma Inc.
4,155,000NT$240.2m0%no data
2.32%
Jing-Hong Chiou
3,281,224NT$189.7m0%no data
2.15%
Junlin Investment Co., Ltd.
3,030,984NT$175.2m0%no data
1.53%
Fosun Industrial Co., Limited
2,157,775NT$124.7m0%no data
1.39%
Taiwania Capital Management Corporation
1,965,146NT$113.6m0%8.45%
0.43%
Min He
600,978NT$34.7m0%no data
0.34%
Mei-Fang Chang
476,000NT$27.5m0%no data
0.25%
Toshiyo Chen
354,083NT$20.5m0%no data
0.17%
Fang-Yu Liu
247,000NT$14.3m0%no data
0.17%
Guo-Chun Song
237,400NT$13.7m0%no data
0.096%
Zhong-Yi Duan
136,167NT$7.9m0%no data
0.083%
State Street Global Advisors, Inc.
116,670NT$6.7m1.8%no data
0.035%
Stephen Cary
50,000NT$2.9m0%no data
0.015%
Hai-Yi Ma
21,000NT$1.2m0%no data